chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diarrhea; Constant vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and VOMITING (Constant vomiting) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder (overactive immune system) and Depression.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced DIARRHOEA (diarrhea) and VOMITING (Constant vomiting). At the time of the report, DIARRHOEA (diarrhea) and VOMITING (Constant vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was taking concomitant medications. No treatment information was provided
Chronic itchy Hives all over my body, Chronic Fatigue, mental fog, depression, anxiety, joint inflammation and pain, visual problems. Malaise.
04/18/2022 I started to get a headache on my left side of head around my eye, 4/22/2022 I spoke with a telehealth urgent care through my insurance and thought that it was a sinus infection that was going on. I was told to get Flonase as well to combat symptoms. 04/23/2022 I started to see blurry vision in my left eye and fairly mild, the pain was also very bad. 04/26/2022 I spoke with my urgent care again and they thought that it was only a sinus issue and needed to keep on the course that I was doing. I dealt with the pain for a few more days. The pain got bad to the point where I was taking ibuprofen every 4 hours and my eye sight was getting very blurry. I saw my optometrist and saw swelling on my optical nerve. 04/29/2022I went to the ER and they ended up admitting me into the hospital and was not release until Tuesday May 3rd. I had 3 MRI's and a lumbar puncture and 4 rounds of steroid infusions. They confirmed that my optic nerve was highly inflamed and the MRI's did not show MS symptoms. Waiting for results of Lumbar puncture and the Neurologist that I was working with believes causation of vaccine possibly. I am not 100% recovered I still do not have 100% vision in my left eye and I still get headaches when I try to work with a computer screen and also throughout the day.
High fever; chills; fatigue; arthralgia; decrease appetite; nausea; This non-serious case was reported by a consumer and described the occurrence of fever in a 39-year-old female patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2023-2024 season) for prophylaxis.   Concomitant products included paracetamol.   On 04-OCT-2023, the patient received FluLaval Quadrivalent 2023-2024 season. On 04-OCT-2023, less than a day after receiving FluLaval Quadrivalent 2023-2024 season, the patient experienced fever (Verbatim: High fever), chills (Verbatim: chills), fatigue (Verbatim: fatigue), arthralgia (Verbatim: arthralgia), decreased appetite (Verbatim: decrease appetite) and nausea (Verbatim: nausea).  The outcome of the fever, chills, fatigue, arthralgia, decreased appetite and nausea were not resolved.   It was unknown if the reporter considered the fever, chills, fatigue, arthralgia, decreased appetite and nausea to be related to FluLaval Quadrivalent 2023-2024 season and Flulaval Tetra Pre-Filled Syringe Device.     It was unknown if the company considered the fever, chills, fatigue, arthralgia, decreased appetite and nausea to be related to FluLaval Quadrivalent 2023-2024 season and Flulaval Tetra Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 08-OCT-2023 The reporter self-reported. The symptoms were not treated. The reporter did not consent to follow up.
Patient had vaccine on Tuesday afternoon.  Wednesday woke up with sore arm and leg but able to work.  Thursday and Friday it was steadily getting worse.  Saturday, patient went to a festival.  He wanted to see granddaughter in parade and also for his business.  It was an extremely hot day but patient drank water.  He was very weak and wife had to help him walk to the site for the parade and auction.  The patient's wife put out on social media his complications and a nurse responded that they needed to go to the ER.  Later that evening patient was unable to hold drink in his hand.  Patient decided to wait until Sunday and see if he felt better.  Sunday he woke up and could not walk.   They went to ER and were admitted. His wife did not know the physicians that were seeing him in the hospital.
pain at injection site.  nausea, chills, headache, joint aches, general unwell feeling.  This started during the afternoon after receiving injection in the morning-Friday.  This continued all the next day-Saturday.  All was resolved by the following morning-Sunday.
Pt developed slight swelling, redness and pain at the injection site the following day.  Pain, redness and warmth remained until 07.02.2020 at which time it was improving.
Drug ineffective; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Sep2022 at 10:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 49 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Autoimmune thyroid disease" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID, start date: 19Nov2008. The following information was reported: COVID-19 (medically significant) with onset Mar2023, outcome "not recovered"; DRUG INEFFECTIVE (medically significant) with onset Mar2023, outcome "not recovered". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received treatment with Paxlovid from 05Mar2023 till 09Mar2023. Patient had no known allergies.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300122138 same patient, different drug/event;
Bivalent Covid given as 2nd dose 4wks and 2d after the first orig  Covid dose because the rules around Covid vaccination couldn't be more complicated if you tried.
Two weeks after vaccine started with upset stomach, nausea, and diarrhea.  Has continued daily to current date of 4-17-2021. Also, at times have headache and chills, but no fever.     Self treatment with Pepto-Bismol, Mylanta, Tylenol and Aleve.  Some relief from treatments, but diarrhea continues every morning.  And stomach nausea & grumbling is almost constant.
Head-to-toe itchy rash; Day after shot had swelling of face; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 16Mar2021 at 14:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. The concomitant medication was taken by the patient (unspecified) within two weeks prior to COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021 day after the shot, the patient experienced swelling of face and on 23Mar2021 by day seven, the patient experienced head-to-toe itchy rash. The events resulted in doctor or other healthcare professional office or clinic visit. Therapeutic measures were taken as a result of events which included treatment with prednisone oral and topical steroid cream from an unspecified date in 2021 and unknown if ongoing. The clinical outcome of the events head-to-toe itchy rash and swelling of face were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
First 48 hours I felt normal flu like symptoms. Except after that the symptoms did not go away. Today is day 7 and the symptoms have changed. I have woken up the last 4 mornings with extremely dry mouth and throat. I feel nasally and extremely tired. The exhaustion lasts throughout the day and night. The dryness is only very bad in the mornings and then slowly goes away throughout the day, but I am still sniffly/nasally throughout the day.
arm was quite sore; arm was/ red; arm / had swelling; This case was reported by a consumer via other manufacturer and described the occurrence of pain in arm in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included glaucoma and blood cholesterol increased. Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose received in November 2018, and experienced arm redness and had swelling, refer case US2021AMR116501).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm, erythema of extremities and swelling arm. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm, erythema of extremities and swelling arm were recovered/resolved.   It was unknown if the reporter considered the pain in arm, erythema of extremities and swelling arm to be related to Shingrix.  Additional details were provided as follows: The patient reported case for herself. The age at vaccination was not reported, however could be 69 or 70 years. The reported medical history as taking statin, a blood pressure medication for high cholesterol and eye drops for glaucoma. The patient did not provide any product names. In 2018, the patient received the Shingrix vaccine. After Shingrix vaccination, the patient experienced that her arm was quite sore, red, and had swelling. The patient stated that there was little more redness and swelling than the Covid vaccine. The reporter consented to follow up. No further information was reported.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR116501:same reporter same patient
1st dose on February of 2020  did not get the 2nd; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in February 2020).   On an unknown date, the patient did not received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.       Additional Information: GSK receipt date: 23-May-2022 Reporter's comment: The patient got her first dose but did not get the second dose. Patient did not want to provide any further information The reporter did not consent to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
This spontaneous report as received from a pharmacist refers to a approximately 61 year old female patient with no drug allergies. The patient's pertinent medical history was none. On 07-JUL-2014 the patient was vaccinated with ZOSTAVAX (Dose/Frequency: 0.65 ml, route: subcutaneously in the left arm) (lot # J014810, expiry date: 21-FEB-2015). On an unknown date in July 2014, the patient developed a reaction slightly above the injection site that consisted of a raised red rash that was hard and hot to the touch. The patient called her physician who prescribed an antibiotic which possibly was clindamycin (manufacturer unknown). The patient was not seen by the patient's primary physician but the physician suspected she might have cellulitis The pharmacist was not sure if that was the physician who prescribed the antibiotic. The outcome of raised red rash that was hard and hot to the touch and cellulitis was reported as not recovered.  No product quality complaint was reported for ZOSTAVAX. Pharmacist stated that the patient stopped by at his pharmacy to let him know about the adverse event however, she had her antibiotic prescription filled at a different unspecified pharmacy. Additional information has been requested.
Red rash noted all over face, neck, shoulders, backs of hands and wrists, tops of feet and ankle area, some on back. Some were small red spots only, some were red and slightly raised. Did not appear to be itchy or bothersome to baby. No fever. By 5:45am on 11/5/13, rash developed even more on face, legs, back, and groin. Spots redder than previous day. No pustules observed.
pt recv vax 6JUN95 & 30JUN97 pt devel varicella;JUL97 pt recovered;
Pain in arm, sore for at least a week. Couldn't rotate arm. Almost, numb feeling. Diff Dx: Injection too superior in deltoid knowing penetration and reaction of flu into bursa sac.
Anal wart outbreak after receiving 1st vaccine.; This is a spontaneous report from a contactable consumer. A male patient of 64-year-old age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was EN6202), first dose on right arm via an unspecified route of administration on 13-MAR-2021 10:15 at unknown DOSE 1, SINGLE for COVID-19 immunization. He received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was ER2613), on left arm via an unspecified route of administration on 03Apr2021, 10:15 for COVID-19 immunization. No medical history reported. Concomitant medication included Multivitamin Allegra (received within 2 weeks of vaccination). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. On 15Mar2021 patient experienced Anal wart outbreak after receiving 1st vaccine. The outcome of Event was not recovered.  No follow up attempts are possible. Information about lot/batch number cannot be requested. No further information is expected.
Information has been received from a licensed visiting nurse concerning a 10 year old white male who on 13-JUL-2007 at 9:30 AM was vaccinated SC on right arm with a second dose of varicella virus vaccine live (Oka/Merck) (Lot # 657647/0535U). It was reported that on 14-JUL-2007 the patient developed 2 inch non-vesicular whelp that was red and warm to touch. No medical attention was sought. No further information is expected. This is one of several reports from the same source.
Patient received Varivax 9/28/99. Exposed to chicken pox week before rash appeared. Chicken pox rash on back, chest, legs, and arms.
could not move left hand; swelling of tongue, could not speak; swelling of tongue, could not speak; disoriented; Neck and shoulder pain; headache; Neck and shoulder pain; I was in lots of pain; Red welt on injection site; Muscle weakness; Swelling of face; Cramps in legs; Irritation; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (could not move left hand), SWOLLEN TONGUE (swelling of tongue, could not speak), APHASIA (swelling of tongue, could not speak), DISORIENTATION (disoriented) and NECK PAIN (Neck and shoulder pain) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (could not move left hand), SWOLLEN TONGUE (swelling of tongue, could not speak), APHASIA (swelling of tongue, could not speak), DISORIENTATION (disoriented), NECK PAIN (Neck and shoulder pain), HEADACHE (headache), ARTHRALGIA (Neck and shoulder pain), MYALGIA (I was in lots of pain), VACCINATION SITE URTICARIA (Red welt on injection site), MUSCULAR WEAKNESS (Muscle weakness), SWELLING FACE (Swelling of face), MUSCLE SPASMS (Cramps in legs) and SKIN IRRITATION (Irritation). On 27-Mar-2021, VACCINATION SITE MOVEMENT IMPAIRMENT (could not move left hand), SWOLLEN TONGUE (swelling of tongue, could not speak), APHASIA (swelling of tongue, could not speak), DISORIENTATION (disoriented), NECK PAIN (Neck and shoulder pain), HEADACHE (headache), ARTHRALGIA (Neck and shoulder pain), MYALGIA (I was in lots of pain), VACCINATION SITE URTICARIA (Red welt on injection site), MUSCULAR WEAKNESS (Muscle weakness), SWELLING FACE (Swelling of face), MUSCLE SPASMS (Cramps in legs) and SKIN IRRITATION (Irritation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported  Treatment medication information were not reported   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24-may-2021 and contain non significant information
20 hours after administration swelling/bulge at injection site; red and warm to the touch.
A report was received from a health professional on 10/23/2002, concerning 70 children under 4 years of age who were inadvertently administered Fluvirin vaccine between approximately 10/01/2002 and 10/23/2002. Between approximately 10/01/2002 and 10/23/2002, 70 children under 4 years of age were inadvertently administered Fluvirin 0.25ml intramuscularly.  None of the vaccinees have exhibited any signs or symptoms of an adverse event but will be closely monitored. There was insufficient information to determine the reporters causality assessment.
On 2/27/21 at 2 am started with the chills, by 6am body aches and very fatigued.  I just slept all day and by the following morning I was back to normal.
Patient described swelling in his arm down to elbow. He came in to show me on 3/11/19. It was a little swollen and a little red. Not hot and no fever since the time of vaccination on 3/1/19. Patient was not in any pain, but was questioning swelling. Told him to show physician since he was going that afternoon for an appointment. Told him that swelling is a reported reaction of the vaccination, but was not completely sure it was related since so many days had passed. Patient stated he did get a steroid injection in his shoulder of the same arm.
pt recv vax 6NOV98 & 9NOV98 c/o severe pain in rt arm;can move arms w/o difficulty;advised to f/u w/PMD:
vax failure to produce pos Hep B s Ab p/completion of recommended series; booster given 20AUG93;
In Dec, I got sick with respiratory issue. I wake up not feeling well. I was coughing, difficultly breathing, and congestive. My oxygen level was at 90 to 92. I went urgent care facility. They did COVID-19, Flu, and RSV test. I tested positive for RSV and negative for the other two. These system lasted for about 8. I went to the ER twice. They just told me to use my emergency inhaler more as needed. I continue to get worst on Dec 13th, my coughing, chest pain, chest pressure and difficultly breathing and my inhaler was not working. So, I went to the ER again. They did an EKG, blood work, chest x-ray, chest CT scan, breathing treatments, COVID-19, and RSV. The RSV was still positive. They did get me medicine to take. It did seem to help but by Dec 18th, I was sick again and back in ER. They did another COVID-19, negative and a RSV, positive again. They did breathing treatment and to my to take over-the-counter medicine. I still was still coughing and congestive all through January.
Information has been received from a registered nurse concerning a 11 year old female patient who on 08-JUN-2009 was vaccinated with the first dose of GARDASIL. On 10-AUG-2009, the patient was vaccinated with the second dose of GARDASIL during the morning and that night the patient had hives from head to toe. The nurse stated that the patient did not have a reaction to the first dose of GARDASIL. On an unspecified date the patient recovered from hives from head to toe. Additional information has been requested.
Excessive chills 4 hours after injection and  starting on the second day after the injection  I had 2 nights in a row of night sweats
Telephone call from client on 10-19-05 pm.  Stated right upper arm is very swollen, tender, red and warm to touch - RN instructed client to notify PMD.  Health Department nurse did not see local reaction.
Vomiting since last visit. Was seen in office and in ER on 6/1/07. Recd IV fluids and was sent home.
PATIENT HAD A FAINTING SPELL, BUT DID NOT COMPLETELY PASS OUT. PATIENT LAID DOWN FOR 3O MORE MINUTES.
t103.1, steady, screaming, high pitched @ times; max 45mins @ a time for 3 days p/bax;
Left arm swollen from shoulder to mid-forearm. Started within 24 hours of shot. TX: Told to take Motrin and keep arm elevated.
Near syncope while sitting in lobby, laid her down with feet up, fanned her, and ice pack under neck.
Patient received PNEUMOVAX on 1/7/2010. On 1/8 patient complained of pain at site. On examination site very warm and swollen over large area of right deltoid. patient eventually discharged with no further issues.